Arcturus Therapeutics In... (ARCT)
NASDAQ: ARCT
· Real-Time Price · USD
19.48
0.25 (1.30%)
At close: Aug 15, 2025, 3:59 PM
19.17
-1.62%
After-hours: Aug 15, 2025, 07:54 PM EDT
Arcturus Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 28.3M | 29.38M | 21M | 38.81M | 45.98M | 32.6M | 25.08M | 43.38M | 9.56M | 79.73M | 160.05M | 13.37M | 27.09M | 5.24M | 5.79M | 2.44M | 2M | 2.13M |
Cost of Revenue | n/a | n/a | 819K | 900K | 900K | 904K | 815K | 800K | 52.67M | 51.21M | 22.28M | 37.69M | 38.19M | 44.89M | 30.73M | 45.4M | 45.68M | 50.05M |
Gross Profit | n/a | 29.38M | 21M | 2.54M | 45.08M | 31.69M | 27.4M | -5.94M | -43.1M | 28.52M | 137.77M | -24.32M | -11.1M | -39.65M | -24.94M | -42.96M | -43.68M | -47.92M |
Operating Income | -11.62M | -16.83M | -33.39M | -10.74M | -21.13M | -30.41M | -18.27M | -19.31M | -55.37M | 14.76M | 121.45M | -36.81M | -22.09M | -50.38M | -37.65M | -53.82M | -53.72M | -57.67M |
Interest Income | 2.57M | 2.77M | -15.8M | 7.64M | 4.15M | 4.02M | 6.89M | 4M | 3.25M | 3.22M | 1.81M | 444K | 168K | 154K | 184K | 192K | 190K | 188K |
Pretax Income | -9.18M | -14.08M | -30.01M | -7.12M | -17.37M | -26.45M | -11.45M | -15.33M | -51.97M | 50.86M | 118.64M | -35.27M | -21.56M | -51.17M | -38.66M | -54.08M | -54.58M | -56.35M |
Net Income | -9.18M | -14.08M | -30M | -6.9M | -17.22M | -26.82M | -11.71M | -16.22M | -52.55M | 50.75M | 117.35M | -34.5M | -21.56M | -51.96M | -38.66M | -54.08M | -54.58M | -56.35M |
Selling & General & Admin | 10.34M | 11.31M | 12.38M | 13.28M | 11.42M | 14.85M | 11.69M | 13.38M | 13.22M | 13.76M | 11.86M | 12.49M | 10.99M | 10.73M | 10.81M | 10.86M | 10.04M | 9.74M |
Research & Development | 29.58M | 34.89M | 43.78M | 39.13M | 36.34M | 53.57M | 26.82M | 51.08M | 52.67M | 51.77M | 26.98M | 37.69M | 38.19M | 44.89M | 32.63M | 45.4M | 45.68M | 50.05M |
Other Expenses | n/a | n/a | -1.77M | -39.13M | n/a | -21.63M | n/a | -25.69M | n/a | -556K | -244K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 39.92M | 46.21M | 54.39M | 13.28M | 47.76M | 46.79M | 38.51M | 38.76M | 64.94M | 64.97M | 38.6M | 50.18M | 49.18M | 55.62M | 43.44M | 56.26M | 55.72M | 59.79M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | 4K | 20K | n/a | 743K | 790K | 765K | 728K | 718K | 708K | 711K | 710K | 546K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | -900K | n/a | -815K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 39.92M | 46.21M | 54.39M | 40.38M | 48.66M | 63.01M | 43.35M | 39.56M | 64.94M | 64.97M | 38.6M | 50.18M | 49.18M | 55.62M | 43.44M | 56.26M | 55.72M | 59.79M |
Income Tax Expense | 4K | -16.85M | -4K | -217K | -150K | 368K | 262K | 893K | 577K | 103K | 1.29M | -765K | n/a | 790K | 59K | -20K | -95K | n/a |
Shares Outstanding (Basic) | 27.13M | 27.11M | 27M | 27.06M | 26.97M | 26.88M | 26.63M | 26.57M | 26.56M | 26.55M | 26.51M | 26.47M | 26.43M | 26.38M | 26.35M | 26.34M | 26.32M | 26.24M |
Shares Outstanding (Diluted) | 27.13M | 27.11M | 27M | 27.06M | 26.97M | 26.88M | 26.63M | 26.57M | 26.56M | 27.15M | 27.08M | 26.47M | 26.43M | 26.38M | 26.36M | 26.34M | 26.32M | 26.24M |
EPS (Basic) | -0.34 | -0.52 | -1.11 | 0.14 | -0.64 | -1 | -0.32 | -0.61 | -1.98 | 1.91 | 4.43 | -1.3 | -0.82 | -1.97 | -1.47 | -2.05 | -2.07 | -2.15 |
EPS (Diluted) | -0.34 | -0.52 | -1.11 | 0.14 | -0.64 | -1 | -0.32 | -0.61 | -1.98 | 1.87 | 4.33 | -1.3 | -0.82 | -1.97 | -1.47 | -2.05 | -2.07 | -2.15 |
EBITDA | -11.62M | -16.02M | -17.85M | -9.82M | -16.47M | -25.55M | -7.49M | -18.49M | -51.27M | 52.18M | 122M | -34.1M | -20.3M | -50.16M | -37.49M | -53.08M | -53.72M | -56.74M |
EBIT | -9.18M | -16.83M | -18.67M | -10.74M | -17.37M | -26.45M | -18.27M | -19.31M | -51.97M | 51.6M | 121.45M | -34.5M | -20.7M | -50.45M | -37.95M | -53.12M | -53.87M | -57.05M |
Depreciation & Amortization | n/a | 801K | 819K | 912K | 900K | 904K | 815K | 827K | 700K | 578K | 551K | 400K | 400K | 224K | 310K | 300K | 300K | 307K |